NHS

News

NHS grants fast-track access to Takeda's lung cancer drug Ex...

Takeda has secured UK approval for its lung cancer therapy Exkivity, with an NHS access deal that could see it prescribed to patients within the next few weeks.

News

~ai-9d6a62d3-dfc0-4e08-82a5-ed2a25f94450_

Real-time Abbott glucose monitor available to NHS after UK l...

The latest version of Abbott's FreeStyle Libre continuous glucose monitor is now available via the NHS to eligible people with di

News

NICE says no to Keytruda in triple-negative breast cancer

There isn't enough evidence to support the use of Merck & Co/MSD's Keytruda in combination with chemotherapy as a first-line treatment for advanced triple negative breast cancer, accord

News

Ex-NHS Digital head says merger into NHS England is a mistak...

The former chair of NHS Digital has slammed the decision to absorb the unit into NHS England as a "significant retrograde step" that could undermine citizens' rights over their health data.

News

Great Britain £50 - fifty pounds sterling notes spead out.

UK govt pledges £260m to health data, manufacturing

The UK biopharma industry has welcomed a new tranche of funding from the government aimed at bolstering manufacturing of medicinal products and developing the national health data infrastru

R&D

One year on: How is the UK’s vision of a future-proof resear...

One year ago, a UK-wide vision for the country’s future research landscape promised streamlined processes, and a patient-centred, competitive environment.

NHS grants fast-track access to Takeda's lung cancer drug Ex...

Real-time Abbott glucose monitor available to NHS after UK l...

NICE says no to Keytruda in triple-negative breast cancer

Ex-NHS Digital head says merger into NHS England is a mistak...

UK govt pledges £260m to health data, manufacturing

One year on: How is the UK’s vision of a future-proof resear...

GBL joins CVC in €10.7bn takeover bid for Recordati

Discover a new era of healthcare panel engagement: Grounded ...

NHS

Editor's Picks